Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shandong Fengyuan Chemical Co., Ltd. (002805.SZ)
Zaozhuang, CN
Shandong Fengyuan Chemical Co., Ltd. (SFCC) specializes in the development, manufacturing, and global distribution of a variety of chemical products. The company's core offerings include industrial and refined grades of oxalic acid, alongside numerous oxalate compounds, which it supplies to both Chinese domestic and international clients. Beyond these, SFCC's extensive product portfolio also features critical substances like potassium tetroxalate, lithium iron phosphate, potassium binoxalate, sodium nitrate, and essential lithium cathode materials. These chemical solutions are integral to a diverse range of industries and emerging sectors. They find vital applications in traditional fields such as pharmaceuticals, rare earth processing, fine chemicals, daily consumer products, and textile printing and dyeing. Furthermore, SFCC's products cater to cutting-edge areas including biopharmaceuticals, new energy vehicles, and environmental protection initiatives. Established in Zaozhuang, China, in the year 2000, the company has its headquarters in that location.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.33% | -6.39% | +3.76% | +28.66% | +5.95% | +21.55% | +84.03% | +8.18% | +63.43% | +441.98% | +441.98% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+56.2% ★ Q1'26: +276.5% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-34.1% Q1'26: +184.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-27.6% Q1'26: -0.3% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%-19.8% Q1'26: +12.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%-17.1% Q1'26: +25.9% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-0.3% ★ Q1'26: +1.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×-9.36× Q1'26: 2.11× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|
| Revenue |
1.74B
est: 8.21B (-78.9%)
|
2.78B
est: 8.21B (-66.2%)
|
1.49B
est: 15.22B (-90.2%)
|
2.33B
est: 17.24B (-86.5%)
|
| EBITDA |
270.41M
est: 107.87M (+150.7%)
|
-311.80M
est: 107.87M (-389.0%)
|
-190.85M
est: -72.76M (-162.3%)
|
-173.79M
est: -82.38M (-111.0%)
|
| EBIT |
214.99M
est: -460.83M (+146.7%)
|
-435.25M
est: -460.83M (+5.6%)
|
-387.39M
est: -1.21B (+68.0%)
|
-459.66M
est: -1.37B (+66.5%)
|
| Net Income |
150.88M
|
-389.32M
|
-362.23M
|
-485.20M
|
| SGA |
56.18M
est: 111.78M (-49.7%)
|
70.34M
est: 111.78M (-37.1%)
|
51.40M
est: 401.29M (-87.2%)
|
21.96M
est: 454.33M (-95.2%)
|
| EPS |
0.59
|
-1.39
|
-1.29
|
-1.73
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cheng Zhao | Deputy GM & Director | — | male |
| Lin Pang | Financial Director | — | male |
| Lingguo Chen | Deputy GM & Director | — | male |
| Peng Jiang | Accounting Supervisor | — | — |
| Wen Qin Ni | Secretary of the Board of Directors | — | female |
| Yan Deng | GM & Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002805.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
